Maven Income and Growth VCT 3 (MIG3) Share Price, News & Analysis

Company Overview

Maven Income and Growth VCT 3 PLC is a venture capital trust fund specializing in development capital and early stage investments. In case of private companies, the fund prefers to invest in later stage. It does not invest in hostile public to private transactions. The fund's objective is to achieve long-term capital appreciation principally through investment in smaller unquoted companies and AIM quoted companies in the United Kingdom with strong growth potential. It invests up to £1million ($1.65 million) in any company in one year and no more than 15 percent of the company's assets by cost in one business at any time. The fund seeks to take a Non-Executive Board seat on its investee companies. It may co-invest in case of larger deals.

Key Stats

• Today's Range: 48 to 49
• 50-Day Range: 48 to 49.80
• 52-Week Range: 46 to 51
• Volume: 1,221 shs
• Average Volume: 14,386 shs
• Market Capitalization: £59.83 million
• P/E Ratio: 82.10
• Dividend Yield: 6.25%
• Price Target: N/A
• Consensus Rating: N/A

MIG3 Stock Analysis - Frequently Asked Questions

How have MIG3 shares performed this year?

Maven Income and Growth VCT 3's stock was trading at GBX 48 on January 1st, 2025. Since then, MIG3 shares have increased by 0.0% and is now trading at GBX 48.
View the best growth stocks for 2025 here.

How do I buy shares of Maven Income and Growth VCT 3?

Shares of MIG3 stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Maven Income and Growth VCT 3 own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Maven Income and Growth VCT 3 investors own include Starwood Waypoint Homes of Ben (SFR), Ultragenyx Pharmaceutical (RARE) and Centerstate Bank (CSFL).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Financial Services
• Industry: Asset Management
• Sub-Industry: N/A
• Current Symbol: LON:MIG3
• CUSIP: N/A
• CIK: N/A
• Web: www.mavencp.com
• Phone: +44-20-31022750
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX 0.58
• Trailing P/E Ratio: 82.10
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £728,797.52
• Net Margins: 26.21%
• Pretax Margin: N/A
• Return on Equity: 1.12%
• Return on Assets: -2.94%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: 318.10

Sales & Book Value

• Annual Sales: £2.78 million
• Price / Sales: 21.52
• Cash Flow: GBX 17.39 per share
• Price / Cash Flow: 2.76
• Book Value: GBX 53.60 per share
• Price / Book: 0.90

Miscellaneous

• Outstanding Shares: 124,653,000
• Free Float: N/A
• Market Cap: £59.83 million
• Optionable: Not Optionable
• Beta: 0.13